Market Research Report
Global Vascular Graft Market Analysis (2018-2024)
|Published by||KBV Research||Product code||745742|
|Published||Content info||389 Pages
Delivery time: 1-2 business days
|Global Vascular Graft Market Analysis (2018-2024)|
|Published: November 12, 2018||Content info: 389 Pages||
The Global Vascular Graft Market size is expected to reach $4.3 billion by 2024, rising at a market growth of 7.3% CAGR during the forecast period. A vascular graft is a medical device which is used as an artificial blood vessel. These devices are implanted into patients suffering from blocked blood vessels. They are used to redirect flow of blood from one area to another. This restores normal flow of blood within the body.
Growing occurrence of vascular disorders, high blood sugar, hypertension, and other risk factors which lead to blocked blood vessels are the factors that propel the vascular Graft market. Growing geriatric population, technological advancements, and changes in life style (consumption of junk food, tobacco, and alcohol) are other complimenting factors that will drive the market growth during the forecast period. However, cost associated with the treatment, and complications associated with prosthetic Graft are the factors that hamper the growth of this market.
On the basis of product, the market report segments the market into Endovascular Aneurysm Repair Stent Grafts, Hemodialysis Access Graft, Peripheral vascular graft, and Coronary Artery By-pass graft. Endovascular Aneurysm Repair Stent Graft are further segmented into Abdominal Aortic Aneurysm (AAA) and Thoracic Aortic Aneurysm (TAA). Abdominal Aortic Aneurysm (AAA) is further sub segmented into Complex and Traditional (AAA). Raw material is categorized into Polytetrafluoroethylene (PTFE), Biosynthetic, Polyester, and Polyurethane (PU). The end users covered under the report are Hospitals and Ambulatory Surgical Centers. By application the market is divided into Cardiovascular Diseases, Aneurysm, Kidney failure, vascular Occlusion, and other Applications. Additionally, cardiovascular disease is further bifurcated into Coronary Artery Disease, Cardiac Aneurysm, Hypertension, and Cardiac Stroke. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa (LAMEA).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include B. Braun Melsungen AG, Cardinal Health, Medtronic Plc, Vingmed Danmark A/S, Cook Medical, Lemaitre Vascular, Inc., Terumo Medical Corporation, Endologix, Inc., W. L. Gore & Associates, Inc., and Getinge AB.